General Healthcare Ltd. v. Qashat

254 F. Supp. 2d 193, 2003 U.S. Dist. LEXIS 5258, 2003 WL 1785769
CourtDistrict Court, D. Massachusetts
DecidedMarch 31, 2003
DocketCIV.A.2000-10191-RBC
StatusPublished
Cited by1 cases

This text of 254 F. Supp. 2d 193 (General Healthcare Ltd. v. Qashat) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
General Healthcare Ltd. v. Qashat, 254 F. Supp. 2d 193, 2003 U.S. Dist. LEXIS 5258, 2003 WL 1785769 (D. Mass. 2003).

Opinion

MEMORANDUM AND ORDER ON PLAINTIFF GENERAL HEALTHCARE LIMITED’S MOTION FOR SUMMARY JUDGMENT (#45) AND DEFENDANTS’ MOTION FOR SUMMARY JUDGMENT (#52)

COLLINGS, United States Magistrate Judge.

I. Introduction

On February 1, 2000, plaintiff General Healthcare Limited (hereinafter “GHL”) filed a three count complaint (# 1) against defendants Isam Qashat (hereinafter “Qas-hat”) and Kent International Products, Inc. (hereinafter “KIP”) alleging two claims of unfair competition and false advertising under the Lanham Act and seeking cancellation of certain trademark registrations all in relation to the defendants’ use of the KENT trademark and the plaintiffs alleged proprietary trade dress. Approximately a month and a half later the defendants filed an answer to the complaint along with counterclaims for trademark infringement against GHL. (# 4) GHL duly filed its answer to the counterclaims (# 8) on April 12, 2000.

Thereafter discovery was undertaken, albeit with a few skirmishes. On March 15, 2002, with the parties’ consent, this case was referred and reassigned to the undersigned for all purposes including trial and the entry of judgment pursuant to 28 U.S.C. § 636(c). Discovery was then completed in June, 2002, and a schedule for the filing of cross-motions for summary judgment issued. (# 43)

On June 25, 2002, the parties submitted a joint statement of stipulated facts. (# 51) About a week later on July 1, 2002, the following papers were filed: GHL’s motion for summary judgment (#45) as well as its memorandum in support (# 46), its statement of facts (# 47) and three declarations. (48, 49, 50) On even date the defendants too filed their summary judgment motion (# 52) together with a memorandum in support (# 53), a statement of facts (# 54) and an affidavit with exhibits. (# 55) The plaintiff filed its opposition to the defendants’ dispositive motion (# 56) and its reply/response to the Rule 56.1 statement (# 57) on July 15, 2002. Similarly, the defendants timely filed their opposition to GHL’s summary judgment motion (# 58), their Local Rule *195 56.1 statement of facts (# 59) and another declaration. (# 60) Both sides submitted their reply memoranda in support of their respective motions on July 26, 2002 1 (61, 62)

A hearing on the summary judgment motions was held on March 24, 2003. With the record now complete, the parties’ cross-motions for summary judgment are in a posture for resolution.

II. The Facts

As noted, the parties have filed a fairly extensive joint statement of stipulated facts (# 51) that shall be repeated herein essentially verbatim, absent quotations.

In or about 1982, Healthcare International (“HCI”) began manufacturing and selling a product used for hair lightening under the trademarks KENT and KENT CREME BLEACH. HCI was a corporation of the state of Connecticut, which has been dissolved. HCI’s principal was Salvatore Rodino.

On May 5,1986, HCI filed an application with the United States Patent and Trademark Office (“USPTO”) to register the mark KENT CREME BLEACH. On September 29, 1986, the USPTO issued to HCI a final refusal to register the said mark. HCI did not respond to that office action, and accordingly HCI was deemed to have abandoned its application to register the mark effective March 30, 1987, as reflected in the USPTO’s records.

Salvatore Rodino died in February 1988.

GHL is a British Company with its principal place of business in the United Kingdom. GHL’s principal is Adel Kseib.

In February 1989, Adel Kseib met. with Mr. Rodino’s widow, Lena Rodino, in New York City. Other people, including Mr. Rodino’s son Mark Rodino, and a person by the name of Nisso Benatar, may have been present at that meeting as well. At the meeting, Mr. Kseib made a payment to Lena Rodino. Subsequently, Mrs. Rodino signed letters to at least one of HCI’s manufacturers and suppliers asserting that the KENT trademark had been sold to Mr. Kseib of GHL.

Since its alleged acquisition of the marks in 1989, GHL had not sold any products under the marks KENT or KENT CREME BLEACH in the United States, nor has GHL applied to register either of the KENT marks in the United States.

After the February 1989 meeting, GHL began gearing up to sell products under the KENT name in the Middle East. To do so they contacted and ultimately used at least one of HCI’s former manufacturers or suppliers. In 1990, GHL began manufacturing its KENT CREME BLEACH product, using the identical trademarks and trade dress that had previously been used by HCI.

Since 1990, GHL has used a manufacturer, Corwood Laboratories, in the United States to make the creme for its product bearing the KENT marks. Since 1990, the tubes for the creme, which are affixed with the KENT trademark, have also been made by a company in the United States. From 1990 to 1995 or 1996 assembly of GHL’s product took place in the United States, with the final products being shipped, by a company named Colora, to GHL in the United Kingdom. GHL then sold the product from its offices in the United Kingdom to customers in the Middle East. Since around 1995 or 1996, the boxes and inserts for GHL’s product bearing the KENT marks have been made in the United Kingdom, and final assembly of GHL’s products has been done by GHL in *196 the United Kingdom. At all times, GHL’s fully assembled KENT product has been sold by GHL only from the United Kingdom only to buyers in the Middle East.

In 1989, Qashat contacted counsel and indicated he was interested in using the trademarks KENT and KENT CREME BLEACH in the United States and inquired as to their legal availability. Qas-hat’s counsel determined that the marks were available to use and register and advised Qashat as such.

On July 9, 1990, Qashat filed an application to register the mark KENT CREME BLEACH with the USPTO. At least as early as that month (July 1990), Qashat began selling creme bleach products under the KENT marks.

The trademarks and trade dress used by KIP for its KENT CREME BLEACH were copied from, and are virtually identical to, those previously used by HCI. The specimens of use submitted by Qashat to the USPTO consisted of packaging that was likewise virtually identical in appearance to that which had previously been used by HCI. During the application process for KENT CREME BLEACH, Qas-hat listed himself as the applicant with the d/b/a “Hair Care International.”

GHL did not file any opposition to Qas-hat’s 1990 trademark application when the mark was published for opposition. The trademark registration for KENT CREME BLEACH issued to Qashat on June 23, 1992 by the USPTO, under U.S. Trademark Registration No. 1,692,744. Qashat subsequently assigned that registration to KIP. After the mark had been registered for over five years, KIP filed its affidavit of incontestability pursuant to Section 15 of the Trademark Act, which was accepted and acknowledged by the USPTO on August 12, 1998. GHL never filed a petition to cancel this registration with the PTO.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

DIALOGO, LLC v. Bauza
467 F. Supp. 2d 115 (D. Massachusetts, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
254 F. Supp. 2d 193, 2003 U.S. Dist. LEXIS 5258, 2003 WL 1785769, Counsel Stack Legal Research, https://law.counselstack.com/opinion/general-healthcare-ltd-v-qashat-mad-2003.